The University of Colorado and the Colorado Buffaloes football program suffered a tremendous loss with junior quarterback Dominiq Ponder's tragic death Sunday morning in a single-car crash in Boulder.

Astellas is aiding Vir Biotechnology’s oncology pivot with a $1.7 billion global collaboration focused on a potential best-in-class T-cell engager (TCE) for prostate cancer. Under the leadership of ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

This biotech company has a track record of commercializing products and delivering growth. It also has strengths in research and development. When you think of biotech companies, you may think of ...

There are hundreds of biotechnology companies today that have never commercialized a drug. For many years, the standard approach in the industry has been to advance the science, prove the asset, and ...

For centuries, Oxford has been synonymous with academic excellence, with its historical university shaping generations of thinkers. Nowadays, the city is also an iconic biotech hub, making up part of ...

Biotech companies could add growth to your portfolio -- and in some cases, at a bargain price. It’s a great idea to select tomorrow's potential winners and hold on as their stories unfold. If you're ...

US President Donald Trump plans to nominate biotechnology investor Jim O’Neill to be the next leader of the National Science Foundation (NSF), a White House spokesperson confirmed to Nature. The NSF, ...

The following op-ed was published in Nature on February 12, 2026, and was written by Lizzi C. Lee, Fellow on Chinese Economy at ASPI's Center for China Analysis (CCA), and Jing Qian, Vice President, ...

Unnatural Products is proving to be a natural at securing partnerships, this time linking up with Novartis in a deal that could garner up to $1.7 billion in biobucks. Novartis is shelling out $100 ...

In a world where AI unicorns are securing valuations in the tens and hundreds of billions of dollars, biotech startups can’t compete for giant rounds. But while the space may be lower-profile, it’s ...

Vision loss remains one of the leading causes of disability worldwide, with millions affected by inherited retinal diseases, age-related macular degeneration, and diabetic eye disease. While existing ...